Follow
Michael M. Murata
Title
Cited by
Cited by
Year
NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival
MM Murata, X Kong, E Moncada, Y Chen, H Imamura, P Wang, MW Berns, ...
Molecular biology of the cell 30 (20), 2584-2597, 2019
1292019
Quantitative assessment reveals the dominance of duplicated sequences in germline-derived extrachromosomal circular DNA
L Mouakkad-Montoya, MM Murata, A Sulovari, R Suzuki, B Osia, ...
Proceedings of the National Academy of Sciences 118 (47), e2102842118, 2021
162021
Absence of REV3L promotes p53-regulated cancer cell metabolism in cisplatin-treated lung carcinoma cells
L Kong, MM Murata, MA Digman
Biochemical and biophysical research communications 496 (1), 199-204, 2018
102018
The fragility of a structurally diverse duplication block triggers recurrent genomic amplification
R Suzuki, MM Murata, N Manguso, T Watanabe, L Mouakkad-Montoya, ...
Nucleic acids research 49 (1), 244-256, 2021
72021
Optical and Electron Microscopy for Analysis of Nanomaterials
H Kim, MM Murata, H Chang, SH Lee, J Kim, JH Lee, WY Rho, BH Jun
Nanotechnology for Bioapplications, 277-287, 2021
62021
Synthesis method of asymmetric gold particles
BH Jun, M Murata, E Hahm, LP Lee
Scientific reports 7 (1), 2921, 2017
42017
Genome-Wide Analysis of Palindrome Formation with Next-Generation Sequencing (GAPF-Seq) and a Bioinformatics Pipeline for Assessing De Novo Palindromes in Cancer Genomes
MM Murata, AE Giuliano, H Tanaka
Cancer Systems and Integrative Biology, 13-22, 2023
32023
Luminescent Nanomaterials (I)
H Chang, MM Murata, WY Rho, J Kim, JH Lee, SH Lee, DH Jeong, ...
Nanotechnology for Bioapplications, 67-96, 2021
22021
Facile Synthesis of Cubic Magnetic Up‐Conversion Nanoparticles
XH Pham, WY Rho, HM Kim, E Hahm, E Kang, MM Murata, BH Jun
Bulletin of the Korean Chemical Society, 2020
12020
Publisher Correction: Synthesis method of asymmetric gold particles
BH Jun, M Murata, E Hahm, LP Lee
Scientific Reports 7 (1), 15935, 2017
12017
Abstract A009: Targeting Structural Variants (DNA palindromes) in plasma cell-free DNA for Liquid Biopsy-based Cancer Detection
F Igari, H Tanaka, MM Murata, M Saito, AE Giuliano
Cancer Research 84 (3_Supplement_1), A009-A009, 2024
2024
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNA
H Tanaka, M Murata, F Igari, R Urbanowicz, L Mouakkad, S Kim, Z Chen, ...
2024
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNA
MM Murata, F Igari, R Urbanowicz, L Mouakkad, S Kim, Z Chen, ...
bioRxiv, 2023.10. 25.564058, 2023
2023
TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity
Q Liu, S Chung, MM Murata, B Han, B Gao, M Zhang, TY Lee, E Chirshev, ...
International Journal of Biological Sciences 18 (10), 4203, 2022
2022
Abstract P5-01-24: DNA palindromes as novel genomic targets for unbiased, genome-wide, and rapid pan-cancer screening
MM Murata, L Mouakkad, DD Vizio, AE Giuliano, H Tanaka
Cancer Research 80 (4_Supplement), P5-01-24-P5-01-24, 2020
2020
Fluorescence Lifetime of NADH Reveals PARP-Dependent Increase of Oxidative Phosphorylation Critical for Cell Survival
MM Murata, X Kong, K Yokomori, MA Digman
Biophysical Journal 114 (3), 83a, 2018
2018
Analyses of the Cellular Signaling Responses to DNA Damage and DNA Repair Factor Recruitment Using Fluorescence Lifetimes and Fluctuations
MM Murata
University of California, Irvine, 2018
2018
Restoring p53 Function and Silencing REV3L Suppresses the Cancerous Metabolic Phenotype in Cisplatin Treated Human Non-Small Lung Carcinoma Cells
L Kong, MM Murata, MA Digman
bioRxiv, 200816, 2017
2017
Fluorescence Lifetime Mapping of NADH Reveals DNA Repair Activity in Live Cells
M Murata, X Kong, K Yokomori, M Digman
Biophysical Journal 110 (3), 64a-65a, 2016
2016
Microscopic (FLIM) analysis of NADH state changes during cell cycle progression in cancer cells.
C Goul, M Murata, MA Digman, S Rafelski
MOLECULAR BIOLOGY OF THE CELL 25, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20